Stay updated on Roll Over Study 1199.30 BIBF 1120 Clinical Trial
Sign up to get notified when there's something new on the Roll Over Study 1199.30 BIBF 1120 Clinical Trial page.

Latest updates to the Roll Over Study 1199.30 BIBF 1120 Clinical Trial page
- CheckyesterdayChange DetectedRevision note updated from v3.4.0 to v3.4.1. There are no changes to the study details, eligibility criteria, or results displayed on this page.SummaryDifference0.0%

- Check2 days agoChange DetectedThe page shows a revision label update from v3.4.0 to v3.4.1. The new label appears as 'Revision: v3.4.1' and the old label 'Revision: v3.4.0' is removed.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.1%

- Check23 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed as part of administrative site updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check45 days agoChange DetectedThe study Locations section was updated to reflect changes in site availability, adding new locations (South Australia, Western Australia, Nova Scotia, Ontario) and removing others, and the page revision was updated to v3.3.3.SummaryDifference0.4%

- Check74 days agoChange DetectedPublications section updated to note that PubMed auto-fills publications, and the revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Roll Over Study 1199.30 BIBF 1120 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roll Over Study 1199.30 BIBF 1120 Clinical Trial page.